Shenouda Maged (CIK 1658369) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-16). Recent activity: Buy RLMD (11,665 shares), Buy RLMD (500,000 shares), Buy RLMD (50,000 shares), Buy RLMD (90,000 shares), Buy RLMD (60,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-16 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 11,665 | $48,060 |
| 2025-11-06 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 500,000 | $1.1M |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 50,000 | $22,000 |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 90,000 | $44,100 |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | Buy | 60,000 | $31,200 |
Source: SEC Form 4 filings · as of 2025-12-16